Oxford Science Enterprises enters agreement with Lothbury to develop state-of-the-art R&D facilities in Oxford City Centre.
- 30,000 sqft of state-of-the-art laboratory and office space, is part of a comprehensive redevelopment of The Clarendon Centre
- New facilities will expand the availability of high-quality, purpose-built R&D space in Oxford to support the growth of early-stage life science businesses, including those founded by Oxford Science Enterprises
- New space significantly expands Oxford Science Enterprises’ existing 55,000 sqft. property portfolio
Oxford Science Enterprises, investment partner of the University of Oxford, earlier this year announced plans to develop high-specification laboratory and office space, for early-stage life science businesses, in the heart of Oxford city centre.
The 30,000 sqft. R&D space is part of a proposed comprehensive £200 million redevelopment of the Clarendon Centre which is expected to begin in 2022 after Councillors unanimously approved the project. On completion, expected during 2024, the R&D space will provide an ideal environment for fast-growing life science companies. In addition to R&D facilities, plans for the overall 250,000 sqft. site include creating space for student accommodation, offices, retail outlets and restaurants.
In Oxford, the press statement comments, “demand for laboratory space is approximately ten times greater than existing supply. With more than 100 companies in its portfolio, Oxford Science Enterprises has an ever-increasing requirement for specialist laboratory and office space. The redevelopment of the Clarendon Centre will significantly increase Oxford Science Enterprises’ existing 55,000 sqft. footprint in and around Oxford and enhance its ability to provide its companies with the essential facilities needed to grow and thrive”.
Read More HERE.